Authors:
Jaeckle, KA
Phuphanich, S
van den Bent, MJ
Aiken, R
Batchelor, T
Campbell, T
Fulton, D
Gilbert, M
Heros, D
Rogers, L
O'Day, SJ
Akerley, W
Allen, J
Baldas, S
Gertler, SZ
Greenberg, HS
LaFollette, S
Lesser, G
Mason, W
Recht, L
Wong, E
Chamberlain, MC
Cohn, A
Glantz, MJ
Guthell, JC
Maria, B
Moots, P
New, P
Russell, C
Shapiro, W
Swinnen, L
Howell, SB
Citation: Ka. Jaeckle et al., Intrathecal treatment of neoplastic meningitis due to breast cancer with aslow-release formulation of cytarabine, BR J CANC, 84(2), 2001, pp. 157-163
Authors:
Yau, JC
Gertler, SZ
Hanson, J
Verma, S
Grimard, LJ
Malik, ST
Aref, IM
Cross, PW
Tomiak, EM
Stewart, DJ
St Cyr, DA
Huan, SD
Citation: Jc. Yau et al., A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma, AM J CL ONC, 23(3), 2000, pp. 292-296
Authors:
Stewart, DJ
Goel, R
Gertler, SZ
Huan, S
Tomiak, EM
Yau, J
Cripps, C
Evans, WK
Citation: Dj. Stewart et al., Concurrent use of multiple low dose chemotherapy agents with differing mechanisms of action as a strategy vs passive resistance: A pilot study, INT J ONCOL, 15(4), 1999, pp. 693-699
Authors:
Earle, CC
Stewart, DJ
Cormier, Y
Evans, WK
Gertler, SZ
Mihalcioiu, C
Walde, PD
Citation: Cc. Earle et al., A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer, LUNG CANC, 22(3), 1998, pp. 235-241